| Robert Wayne Cox, MD | |
|
1850 W Arlington Blvd, Greenville, NC 27834-5704 | |
| (252) 413-6202 | |
| (252) 758-8333 |
| Full Name | Robert Wayne Cox |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 1850 W Arlington Blvd, Greenville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164480026 | NPI | - | NPPES |
| 8910178 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9301276 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Greenville, NC | Home health agency |
| Gentiva Health Services | Washington, NC | Home health agency |
| Community Home Care & Hospice | Wilson, NC | Hospice |
| Vidant Medical Center | Greenville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians East Pa | 1850284571 | 110 |
News Archive
Caesarean section is one of the most common surgeries in the world, with rates continuing to rise, particularly in high- and middle-income countries.
Net sales decreased 8.8% to $123.9 million in the second quarter of 2009 compared with $135.8 million in the second quarter of 2008. Income from operations was $16.6 million in the second quarter of 2009, compared to $16.0 million in the second quarter of 2008. Net loss was $1.2 million in the second quarter of 2009, compared with a net loss of $1.3 million in the second quarter of 2008.
The Canadian Medical Association (CMA) is calling for nominations for its 2011 Award for Excellence in Health Promotion. Introduced in 2003, this award recognizes those outside the health sector who have made a significant contribution toward a healthy population and a healthy community.
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
› Verified 2 days ago
| Entity Name | Physicians East Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598761967 PECOS PAC ID: 1850284571 Enrollment ID: O20040205001222 |
News Archive
Caesarean section is one of the most common surgeries in the world, with rates continuing to rise, particularly in high- and middle-income countries.
Net sales decreased 8.8% to $123.9 million in the second quarter of 2009 compared with $135.8 million in the second quarter of 2008. Income from operations was $16.6 million in the second quarter of 2009, compared to $16.0 million in the second quarter of 2008. Net loss was $1.2 million in the second quarter of 2009, compared with a net loss of $1.3 million in the second quarter of 2008.
The Canadian Medical Association (CMA) is calling for nominations for its 2011 Award for Excellence in Health Promotion. Introduced in 2003, this award recognizes those outside the health sector who have made a significant contribution toward a healthy population and a healthy community.
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Wayne Cox, MD 1850 W Arlington Blvd, Greenville, NC 27834-5704 Ph: (252) 413-6202 | Robert Wayne Cox, MD 1850 W Arlington Blvd, Greenville, NC 27834-5704 Ph: (252) 413-6202 |
News Archive
Caesarean section is one of the most common surgeries in the world, with rates continuing to rise, particularly in high- and middle-income countries.
Net sales decreased 8.8% to $123.9 million in the second quarter of 2009 compared with $135.8 million in the second quarter of 2008. Income from operations was $16.6 million in the second quarter of 2009, compared to $16.0 million in the second quarter of 2008. Net loss was $1.2 million in the second quarter of 2009, compared with a net loss of $1.3 million in the second quarter of 2008.
The Canadian Medical Association (CMA) is calling for nominations for its 2011 Award for Excellence in Health Promotion. Introduced in 2003, this award recognizes those outside the health sector who have made a significant contribution toward a healthy population and a healthy community.
Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
› Verified 2 days ago
Dr. Giselle Devonne Blair, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 315 W 2nd St, Greenville, NC 27834 Phone: 252-507-0588 Fax: 855-937-0774 | |
Dr. Emily L Bray, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Heart Dr, Greenville, NC 27834 Phone: 252-744-4611 Fax: 252-744-3201 | |
Dr. Shivajirao Prakash Patil, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Heart Dr, Greenville, NC 27834 Phone: 252-744-4611 Fax: 252-744-3040 | |
Dr. Jessica Lee Zimmerman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 101 Heart Dr, Greenville, NC 27834 Phone: 252-744-4611 Fax: 252-744-3201 | |
Dr. Ashton Fox Johnson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Greenville, NC 27834 Phone: 252-744-4757 Fax: 252-744-5014 | |
Dr. Celeste T. Jackson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1204 E Fire Tower Rd, Greenville, NC 27858 Phone: 252-744-1122 Fax: 252-744-1133 | |
Dr. Adam Oneal Padgett, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Pitt County Memorial Hospital, Greenville, NC 27834 Phone: 252-847-4268 |